Log inSign up
Proxima
203 posts
Image
user avatar
Proxima
@proximabio
Decode and design the interfaces of life
New York, NY
proximabio.com
Joined September 2020
11
Following
3,027
Followers
  • Pinned
    user avatar
    Proxima
    @proximabio
    Jan 13
    Excited to announce that our team at Proxima (formerly VantAI) has raised $80M in new funding led by @DCVC, with @nvidia, Braidwell, @Roivant, @aixventureshq, Yosemite, Magnetic Ventures, Alexandria Venture Investments, @ModiVentures, and others. We are building the platform
    Image
    00:00
    29K
  • user avatar
    Proxima
    @proximabio
    Mar 21, 2025
    Announcing Neo-1: the world’s most advanced atomistic foundation model, unifying structure prediction and all-atom de novo generation for the first time - to decode and design the structure of life 🧵(1/10)
    Image
    00:00
    332K
  • user avatar
    Proxima
    @proximabio
    Sep 29, 2023
    📢 Exciting News! 📢 We're launching a monthly lecture series on Generative AI in Drug Discovery hosted by Prof. Michael Bronstein & Prof. Bruno Correia, where researchers will present their latest work. Our inaugural session is 📅 next Friday 📅, by @befcorreia and
    Image
    24K
  • user avatar
    Proxima
    @proximabio
    Apr 3, 2025
    We are excited to announce the first alpha release of 💥 peppr - package for evaluation of predicted poses 💥 an open source framework for structural model evaluation Find out more at peppr.vant.ai built on @biotite_python, peppr dramatically simplifies evaluation
    Image
    11K
  • user avatar
    Proxima
    @proximabio
    Apr 1, 2025
    Drug discovery turned out to be too hard, so VantAI has made the important decision to pivot from molecular glues to regular glues, and today we are thrilled to announce a landmark $800B biobucks deal with Elmer’s. CTO Luca Naef (@NaefLuca) explains, “When we first prompted
    Image
    11K
  • user avatar
    Proxima
    @proximabio
    Mar 21, 2025
    Replying to @proximabio
    Neo-1 presents the next generation of atomistic foundation models. A latent diffusion model that simultaneously learns to reason about molecules and their structures. Enabling not just structure prediction, but de-novo design of small molecules, proteins, and more at the same
    Image
    11K
  • user avatar
    Proxima
    @proximabio
    Mar 13, 2024
    📢 The VantAI team is growing in Europe! A picture of today's team lunch in Zurich with @mmbronstein in town. We're hiring for Machine Learning, Engineering, Comp Bio/Chem and all other scientific positions. E-Mail at [email protected]
    Image
    15K
  • user avatar
    Proxima
    @proximabio
    Mar 21, 2025
    Neo-1: Design and Decode the Structure of Life
    Image
    00:00
    6.7K
  • user avatar
    Proxima
    @proximabio
    Mar 21, 2025
    Replying to @proximabio
    Neo-1 is trained to generate molecules and their structures in full-atom resolution from various starting prompts: sequence, structure, properties or masked versions. This makes Neo-1 the most controllable and general atomistic foundation model, replacing a large series of
    Image
    8.6K
  • user avatar
    Proxima
    @proximabio
    Nov 7, 2023
    📢 We are excited to announce the next two lectures, from @charlieharris01, @Buttenschoen and @lipmanya, and a new home for the GenAI in Drug Discovery series hosted by @mmbronstein and @befcorreia Find all details and past lectures at genaiindrugdiscovery.com 📅 On Nov 17th,
    Image
    22K
  • user avatar
    Proxima
    @proximabio
    Apr 22, 2024
    📢 Excited to announce the next speaker: 🗣️ @GabriCorso will talk about his recent work on assessing and addressing generalization in protein-ligand docking 📅 May 17th, 2024; 11am ET / 5pm CET / 8am PST Sign up genaiindrugdiscovery.com As always, moderated by @mmbronstein
    Image
    5.8K
  • user avatar
    Proxima
    @proximabio
    Feb 13, 2024
    We are thrilled to announce a new milestone collaboration with Bristol Myers Squibb (@bmsnews), utilizing our geometric deep learning platform for the rational design of novel molecular glues. Founder & CEO Zachary Carpenter, and Co-Founder & CTO Luca Naef, sat down with
    Image
    12K
  • user avatar
    Proxima
    @proximabio
    Mar 21, 2025
    Replying to @proximabio
    We're also excited to give a glimpse of NeoLink, our experimental data platform using cross-linking mass spectrometry (XLMS) to gather structural data at cellular scale, orders of magnitudes larger than current standards. Neo-1 efficiently integrates these sparse datasets into
    Image
    6.5K
  • user avatar
    Proxima
    @proximabio
    Mar 21, 2025
    Replying to @proximabio
    This would’ve not been possible without the team behind it: @clemensisert, Michael Pun, @emaros96, Thomas Castiglione, Douglas Tischer, @AkdelMehmet, @dannykovtun, @MPegoraro42, Thomas Duignan, @a1zhang, @OleinikovasV, Graham Holt, @ShinaYusuf_, Patrick Kunzmann, Arjun Ramesh,
    10K

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up